FundedIQ
Biotechnology

Huasaiboman Medical Cell Biology: Funding & Investors (Nov 2026)

Huasaiboman Medical Cell Biology is a biotechnology company engaged in providing new cell therapy technologies and solutions.

www.sino-cellbiomed.com Qingdao Shi, China 11-50 employees Founded 2019
Total raised
$30.0M
Rounds
1
Latest
Series B
Nov 2026

Huasaiboman Medical Cell Biology has raised $30.0M across 1 funding round on record, the most recent a Series B of $30.0M announced in Nov 2026.

That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.

Huasaiboman Medical Cell Biology Company Profile and Key Stats

Total funding raised
$30.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$30.0M in Nov 2026
Employees
11-50
reported band
Founded
2019
Headquarters
Qingdao Shi, China
Investors on record
8
5 named below

Latest funding round on record: Nov 2026.

Huasaiboman Medical Cell Biology Funding Rounds

Date
Round
Amount
Series B
$30.0M

Huasaiboman Medical Cell Biology Investors

Hefei Guotou Hefei Industrial Investment Group Life and Health Company Zhangjiang Science & Technology Investment Corporation Guoxin Investment ASBV

8 investors are recorded in total; the 5 named above are those the record identifies.

Huasaiboman Medical Cell Biology Funding in Context

Segment
Companies
Median round
740
$15M
4,483
$32M

Huasaiboman Medical Cell Biology's latest round of $30.0M is above the median round in China. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Huasaiboman Medical Cell Biology in Biotechnology and Qingdao Shi

Companies Similar to Huasaiboman Medical Cell Biology

Fortsense is an AI-aware chip designer, focusing on core component design, outsourcing semiconductor supply…

Series C $60.0M

Phrontline Biopharma develops biopharmaceutical products to treat cancer through innovative antibody-drug…

Series A $40.0M

Lips Semiconductor is a developer and producer of power semiconductor components for new energy vehicles and…

Series B $15.0M

UniX AI develops general-purpose humanoid robots for real-world applications.

Seed $74.9M

Sanyou Bio provides biopharmaceutical research and development services, focusing on the discovery and…

Series C $15.0M

coScene provides data infrastructure, data processing, and research support for spatial intelligence and…

Seed $15.0M

Afana Biotechnology is a company that provides research and development for mRNA technology, sequence…

Series A $50.0M

Lingchuan Technology is a high-tech enterprise focusing on transcoding/AI chip research and development.

Series B $150M

Boyi Biotechnology provides vital raw materials and complete solutions to biomedical customers in the in…

Series B $15.0M

Guoquangzi is a manufacturer of quantum precision measurement devices.

Series B $75.0M

Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for…

Series B $30.1M

Echiev is a developer of autonomous driving technology and application products includes intelligent and…

Series C $30.1M

Huasaiboman Medical Cell Biology Funding FAQs

What does Huasaiboman Medical Cell Biology do?

Huasaiboman Medical Cell Biology is a biotechnology company engaged in providing new cell therapy technologies and solutions.

How much funding has Huasaiboman Medical Cell Biology raised?

Huasaiboman Medical Cell Biology has raised $30.0M across 1 round on record. The most recent is a Series B of $30.0M announced in Nov 2026.

When did Huasaiboman Medical Cell Biology last raise funding?

Huasaiboman Medical Cell Biology's most recent funding round on record is a Series B of $30.0M, announced in Nov 2026.

Who has invested in Huasaiboman Medical Cell Biology?

Investors on record for Huasaiboman Medical Cell Biology include Hefei Guotou, Hefei Industrial Investment Group Life and Health Company, Zhangjiang Science & Technology Investment Corporation, Guoxin Investment, ASBV. FundedIQ records 8 investors in total.

Where is Huasaiboman Medical Cell Biology headquartered?

Huasaiboman Medical Cell Biology is based in Qingdao Shi, China.

How many employees does Huasaiboman Medical Cell Biology have?

Huasaiboman Medical Cell Biology is in the 11-50 employee band.

When was Huasaiboman Medical Cell Biology founded?

Huasaiboman Medical Cell Biology was founded in 2019.

About FundedIQ's Huasaiboman Medical Cell Biology Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Huasaiboman Medical Cell Biology is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.